Peer-reviewed by Dr. Sabrina Berdouk
Why Is This So Important?
- Intubation + mechanical ventilation are invasive, painful, and anxiety-provoking.
- Untreated pain/anxiety → sympathetic surge (↑HR, ↑BP, ↑O₂ consumption, arrhythmias, worse outcomes).
- Paralysis masks pain—paralytics (NMBAs) block movement, not sensation or consciousness.
- Memories of pain are common among survivors; untreated pain is a major source of PTSD.
- Over-sedation: delays extubation, ↑delirium, ↑mortality.
- Under-sedation: ↑agitation, ↑energy use, self-extubation, ventilator dyssynchrony, PTSD.
Bottom line: Balance is everything—enough analgesia/sedation for comfort and safety, but not so much that you harm.
Core Principles (How to Think at the Bedside)
- Pain first, then sedation
- Opioids (e.g., fentanyl) are mainstay for pain control; address pain before layering on sedatives.
- Most sedatives do not relieve pain.
- Propofol, dexmedetomidine, benzodiazepines—primarily sedatives.
- Exceptions: Ketamine and dexmedetomidine also provide some analgesia.
- Avoid benzos when possible.
- ↑Delirium, ↑vent/ICU duration vs. non-benzo protocols.
- Reserve for specific indications: status epilepticus, withdrawal, re-emergence phenomena.
- Avoid long-acting paralytics.
- Outlast induction agents; ↑risk for awake paralysis if sedation/analgesia is missed or underdosed.
- Regularly reassess.
- Minimize depth of sedation (when safe).
- Lighter sedation (RASS −1 to −2) shortens vent/ICU time and reduces delirium.
Recommended Approach (Step-by-Step)
1. Immediately after intubation
- Start with IV bolus opioid (e.g., fentanyl 0.5–1 mcg/kg or 50–100 mcg).
- Start a sedative (e.g., propofol, ketamine, or dexmedetomidine), titrate based on clinical context and goals.
- If paralyzed, ensure deep sedation—cannot use RASS for assessment while paralyzed!
2. Initiate infusions if ongoing mechanical ventilation
- Analgesia:
- Fentanyl: 25–100 mcg/h (titrate to comfort; bolus as needed).
- Hydromorphone: 0.5–3 mg/h (preferred in renal dysfunction).
- Remifentanil: Short half-life, good for rapid titration/weaning.
- Wean opioids when pain source resolves to prevent withdrawal/tolerance.
- Sedation:
- Propofol: 10–30 mcg/kg/min (up to 50–100 short-term). Fast on/off, no analgesia. Beware hypotension/PRIS.
- Dexmedetomidine: 0.2–1.5 mcg/kg/h. No resp depression; delays emergence, less delirium. Not for rapid deep sedation; avoid bolus.
- Ketamine: 0.5–2 mg/kg/h. Hemodynamically stable, analgesic/sedative, increases BP/HR. Avoid in severe CAD, hypertension.
- Special situations:
- Status epilepticus/withdrawal: Benzo + propofol or ketamine.
- Severe asthma/COPD: Ketamine preferred (bronchodilation).
- Alcohol withdrawal: Benzos, consider dexmedetomidine adjunct.
3. Ongoing Care
- Regularly assess:
- RASS for sedation (goal 0 to −2 for most).
- CPOT for pain (goal ≤2).
- Prevent complications:
- Minimize sedative dose over time (“daily sedation vacation” if feasible).
- Prevent/treat delirium (optimize sleep, reorient, mobilize, avoid benzos).
- If using NMBA, monitor with nerve stimulator and ensure sedation.
Common Pitfalls
- Neglecting analgesia—patients are often left in pain while sedatives are prioritized.
- Assuming paralyzed = comfortable—never true! Patients can be aware but unable to communicate.
- Excess sedation—delays extubation, ↑delirium, worsens outcomes.
- Overuse of benzos—linked to worse ICU outcomes.
- Long-acting NMBAs without ongoing sedo-analgesia—risk of awake paralysis.
Medication Quick Reference
| Class | Agent | Dose (Adult) | Pros | Cons | Comments |
|---|---|---|---|---|---|
| Opioid | Fentanyl | 0.5–1 mcg/kg bolus; 25–100/h | Fast, short acting, hemo-stable | Tolerance, withdrawal | Preferred, titrate to comfort |
| Opioid | Hydromorphone | 0.5–2 mg bolus; 0.5–3 mg/h | Longer-acting, renal safe | Slower onset | |
| Opioid | Remifentanil | 0.25–0.5 mcg/kg/min | Ultra-short, easily weaned | Cost | Safe in hepatic/renal failure |
| Sedative | Propofol | 10–30 mcg/kg/min (adults) | Fast, amnestic, neuro-protective | Hypotension, PRIS | No analgesia |
| Sedative | Dexmedetomidine | 0.2–1.5 mcg/kg/h | No resp depression, some analgesia | Bradycardia, hypotension | Good for weaning, delirium |
| Sedative/Analg. | Ketamine | 0.5–2 mg/kg/h infusion | Analgesia + sedation, ↑BP/HR | Emergence, ↑ICP | Hemodynamically friendly |
| Benzo | Midazolam/Loraz. | 1–2 mg IV PRN | Anti-epileptic, withdrawal | Delirium, slow off | Avoid if possible |
Practical Pearls
- Always order both analgesia and sedation for every intubated patient.
- Adjust doses q1–2 h, especially after initial period or when paralytics are running out.
- Target the lowest effective dose; avoid deep sedation unless specifically indicated.
- Prevent and treat ICU delirium (non-pharmacologic measures preferred).
- Don’t forget sleep—minimize nighttime interruptions; use melatonin or quetiapine only if absolutely necessary for severe insomnia/delirium.
Summary Table: Sedation/Analgesia by Clinical Scenario
| Clinical Need | First-Line | Why |
|---|---|---|
| Hemodynamic instability | Fentanyl + Ketamine | Maintains BP, less hypotension |
| Neuroprotection/Status Epil. | Propofol ± fentanyl | Reduces ICP, antiepileptic |
| Severe Asthma/COPD | Ketamine | Bronchodilation |
| Ventilator Weaning | Dexmedetomidine | Cooperative sedation, no resp depression |
| Withdrawal (EtOH/Benzo) | Benzos ± Dexmedetomidine | Treats withdrawal |
| Paralysis (NMB) | Deep analgesia + sedation | Prevent awareness/torture |
Take-Home Messages
- Pain first, then sedation—opioids are your foundation.
- Avoid deep sedation and benzos unless clearly needed.
- Never paralyze without deep sedation/analgesia.
- Regularly reassess pain, sedation, and ventilation synchrony.
- Personalize agent selection to physiology and clinical context.